BMY in the 13F filings
Bristol-myers Squibb Co · CUSIP 110122108
- Quarter end
- 30 Sep 2026
- the date the book describes
- Filed
- 9 Nov 2026
- latest of these filings; the earliest 9 Nov 2026
- Managers listing it
- 2
- at least, of 95 tracked, among listed positions
- Comparable managers
- 5
- filed both Q2 2026 and Q3 2026; 1 listed it in both
- Shares listed
- 12,378,925
- combined, among listed positions
- Reported value
- $772m
- combined, at the quarter end
Among the 5 comparable managers: 1 buyer (opened or added shares) and 1 seller (trimmed or exited), at least, among listed positions. Their net change in shares was +460,947.
Managers listing BMY in Q3 2026
2 of 2 holders
| Action | Filing | |||||
|---|---|---|---|---|---|---|
| Acadian Asset Management LLC | 12,302,971 | $768m | 0.90% | Added | +709,619 | 9 Nov 2026 (the filing on sec.gov) |
| Squarepoint Ops LLC | 75,954 | $4.7m | under 0.1% | Trimmed | -248,672 | 9 Nov 2026 (the filing on sec.gov) |
What managers have written about BMY
Shown because the letter names the company. A letter is commentary; it is not a record of why a position changed.
- Starboard's February 2019 letter to Bristol-Myers Squibb shareholders on the Celgene deal28 Feb 2019 · Activist letter · Subject of the letter · Starboard Value LP’s 13F
- Before the letter
- 31 Dec 2018 (Q4 2018 13F): not among Starboard Value LP’s listed positions. A holding below the listed range, under another security, or none at all would read the same.
- After the letter
- 31 Mar 2019 (Q1 2019 13F): not among Starboard Value LP’s listed positions. A holding below the listed range, under another security, or none at all would read the same.
Largest increases and reductions, by shares
Increases
- Acadian Asset Management LLCexisting position · 12,302,971 shares now+709,619
Reductions
- Squarepoint Ops LLCexisting position · 75,954 shares now-248,672
New positions and exits
New (0)
No new position among listed positions.
Exited (0)
No exit shown by a manager’s own filing.
Ownership over time
Tracked managers listing it, at least.
| Quarter | Holders | Reported value | Buyers | Sellers |
|---|---|---|---|---|
| Q2 2013 | 22 | $12.2bn | n.a. | n.a. |
| Q3 2013 | 24 | $13.4bn | n.a. | n.a. |
| Q4 2013 | 23 | $14.8bn | n.a. | n.a. |
| Q1 2014 | 26 | $14.9bn | n.a. | n.a. |
| Q2 2014 | 25 | $14.7bn | n.a. | n.a. |
| Q3 2014 | 24 | $15.8bn | n.a. | n.a. |
| Q4 2014 | 21 | $18.3bn | n.a. | n.a. |
| Q1 2015 | 29 | $20.3bn | n.a. | n.a. |
| Q2 2015 | 24 | $21.7bn | n.a. | n.a. |
| Q3 2015 | 29 | $19.9bn | n.a. | n.a. |
| Q4 2015 | 29 | $22.5bn | n.a. | n.a. |
| Q1 2016 | 27 | $21.3bn | n.a. | n.a. |
| Q2 2016 | 31 | $24.0bn | n.a. | n.a. |
| Q3 2016 | 33 | $16.9bn | n.a. | n.a. |
| Q4 2016 | 33 | $20.1bn | n.a. | n.a. |
| Q1 2017 | 36 | $17.9bn | n.a. | n.a. |
| Q2 2017 | 36 | $17.8bn | n.a. | n.a. |
| Q3 2017 | 34 | $20.2bn | n.a. | n.a. |
| Q4 2017 | 35 | $19.0bn | n.a. | n.a. |
| Q1 2018 | 32 | $19.3bn | n.a. | n.a. |
| Q2 2018 | 33 | $18.0bn | n.a. | n.a. |
| Q3 2018 | 35 | $19.9bn | n.a. | n.a. |
| Q4 2018 | 36 | $16.6bn | n.a. | n.a. |
| Q1 2019 | 44 | $16.9bn | n.a. | n.a. |
| Q2 2019 | 31 | $16.8bn | n.a. | n.a. |
| Q3 2019 | 31 | $18.0bn | n.a. | n.a. |
| Q4 2019 | 29 | $24.1bn | n.a. | n.a. |
| Q1 2020 | 29 | $18.9bn | n.a. | n.a. |
| Q2 2020 | 35 | $18.0bn | n.a. | n.a. |
| Q3 2020 | 31 | $18.8bn | n.a. | n.a. |
| Q4 2020 | 28 | $16.4bn | n.a. | n.a. |
| Q1 2021 | 31 | $15.2bn | n.a. | n.a. |
| Q2 2021 | 27 | $16.3bn | n.a. | n.a. |
| Q3 2021 | 30 | $14.2bn | n.a. | n.a. |
| Q4 2021 | 28 | $12.9bn | n.a. | n.a. |
| Q1 2022 | 28 | $15.2bn | n.a. | n.a. |
| Q2 2022 | 31 | $14.8bn | n.a. | n.a. |
| Q3 2022 | 27 | $12.2bn | n.a. | n.a. |
| Q4 2022 | 33 | $10.0bn | n.a. | n.a. |
| Q1 2023 | 29 | $8.4bn | n.a. | n.a. |
| Q2 2023 | 29 | $7.9bn | n.a. | n.a. |
| Q3 2023 | 32 | $7.5bn | n.a. | n.a. |
| Q4 2023 | 30 | $7.2bn | 19 | 12 |
| Q1 2024 | 20 | $6.6bn | 12 | 10 |
| Q2 2024 | 26 | $6.4bn | 17 | 10 |
| Q3 2024 | 31 | $7.9bn | 18 | 13 |
| Q4 2024 | 27 | $6.6bn | 14 | 13 |
| Q1 2025 | 20 | $6.6bn | 9 | 13 |
| Q2 2025 | 22 | $5.6bn | 16 | 8 |
| Q3 2025 | 28 | $5.4bn | 19 | 9 |
| Q4 2025 | 25 | $7.7bn | 13 | 27 |
| Q1 2026 | 27 | $8.3bn | 17 | 22 |
| Q2 2026 | 22 | $8.2bn | 15 | 23 |
| Q3 2026 | 1 | $768m | 1 | 1 |
Compare with…
Holders over time, buyers and sellers, and the managers holding both, side by side for up to four stocks.
BMY and LLY →BMY and JNJ →BMY and VRTX →Choose a stock to compare with BMY →
How much of the picture this is
A 13F is a manager’s long US-listed equity book at a quarter end, filed up to 45 days later. It shows no shorts, cash, bonds or performance, and it is never today’s portfolio. Large books are listed to their largest positions, so a manager missing from this table may still hold a small position below that line. These are 95 tracked managers, not the institutional market.
Which funds own BMY, latest filings →Back to the 13F Explorer →